Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 26, 2020
Perrigo and Catalent Pharma Solutions announced the FDA has approved Perrigo’s ANDA for generic albuterol sulfate inhalation aerosol.
read more
Friday, September 25, 2020
The FDA is alerting health care professionals and patients of a recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent for Perrigo due to possible clogging of the inhaler.
read more
Perrigo is taking actions to drive substantial profit growth in 2016 and beyond. In total, the actions are expected to add incremental benefits of $175 million when the full run rate of the plan is achieved.
read more
Perrigo Company has announced that Mr. Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, will have expanded responsibilities that will now include providing leadership and strategic direction to the Company's ...
read more
Thursday, August 09, 2018
Perrigo has entered into a licensing agreement with a subsidiary of Merck for the exclusive rights in the United States to pursue regulatory approval for an OTC Nasonex Nasal Spray.
read more
Monday, February 27, 2017
Perrigo Company has announced that Ron Winowiecki, Senior Vice President, Business Finance, has been appointed acting Chief Financial Officer, effective immediately, following the resignation of Judy L. Brown, Executive Vice President, Business ...
read more
Monday, November 27, 2017
Perrigo announced the launch of an AB rated generic version of Mycolog II Cream (nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/gram).
read more
Thursday, February 07, 2019
Perrigo has received final approval from the FDA for its AB rated Abbreviated NDA referencing Zovirax Cream, 5% (acyclovir cream, 5%) developed in collaboration with Sol-Gel Technologies.
read more
Quotient Sciences and Permira announced a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient.
read more
Permira, a global private equity firm, has announced that a company backed by the Permira funds has signed a definitive agreement to acquire Lyophilization Services of New England, Inc (“LSNE”), a contract development and manufacturing organization ...
read more
Wednesday, August 07, 2019
Cambrex has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.
read more
PerkinElmer announced a research team at NCATS is working with PerkinElmer’s AlphaLISA immunoassay to support the global search for effective COVID-19 therapeutics.
read more
PerkinElmer announced a collaboration with Helix to develop and commercialize exome sequencing-based tests that will empower consumers to make proactive health management decisions.
read more
PerkinElmer announced that it has entered into a definitive agreement to acquire Euroimmun Medical Laboratory Diagnostics AG.
read more
Monday, November 26, 2018
PerkinElmer announced its Vanadis NIPT system has obtained CE-IVD mark for commercialization and distribution throughout Europe and other countries that accept CE marking.
read more